Two strains of reovirus (serotype 1 Lang/TIL and serotype 3 Dearing/T3D) were propagated in Vero cells grown in stationary or agitated cultures in a serum-free medium, M-VSFM. Solid microcarriers (Cytodex-1) were used to support cell growth in agitated cultures with a normal doubling time of 25 h. Cell yields of 1 x 10(6) cells/mL were obtained from an inoculum of 2 x 10(5) cells/mL in 4 days in microcarrier cultures. The growth profile and cell yield was not significantly different from serum-supplemented cultures. The virus titer increased by 3-4 orders of magnitude over a culture period of 150 h. The maximum virus titer in stationary cultures reached >1 x 10(9) pfu/mL for both strains of reovirus in M-VSFM. M-VSFM also supported high viral yields in microcarrier cultures. Both the specific productivity and final viral yield was higher in M-VSFM than serum-supplemented cultures. The high viral productivity suggests that this is a suitable system for the production of reovirus as an oncolytic agent for human therapeutic use.
There currently is little known about the genetic and biological functions of avian reovirus (ARV), an atypical member of the family Reoviridae and the prototype of all nonenveloped viruses that induce syncytia formation. In this study, we created ARV temperature-sensitive (ts) mutants by chemical mutagenesis of ARV strain 138. We developed a novel efficiency of lysis (EOL) screening technique and used it and the classical efficiency of plating (EOP) assay to identify 17 ARV ts mutants. Pairwise mixed infections of these mutants and evaluation of recombinant progeny ts status led to their organization into seven recombination groups. This indicates that these new groups of mutants represent the majority of the ARV genome. To phenotypically characterize the ts mutants, progeny double-stranded RNA (dsRNA) produced at permissive and nonpermissive temperature was measured. Some mutants were capable of dsRNA synthesis at the restrictive temperature (RNA(+)), which indicates the effects of their ts lesions occur after RNA replication. Most mutants were RNA(-), which suggests their mutations affect stages in viral replication that precede progeny genome synthesis.
We determined that the highly pathogenic avian reovirus strain 176 (ARV-176) possesses an enhanced ability to establish productive infections in HD-11 avian macrophages compared to avian fibroblasts. Conversely, the weakly pathogenic strain ARV-138 shows no such macrophagotropic tendency. The macrophage infection capability of the two viruses did not reflect differences in the ability to either induce or inhibit nitric oxide production. Moderate increases in the ARV-138 multiplicity of infection resulted in a concomitant increase in macrophage infection, and under such conditions the kinetics and extent of the ARV-138 replication cycle were equivalent to those of the highly infectious ARV-176 strain. These results indicated that both viruses are apparently equally capable of replicating in an infected macrophage, but they differ in the ability to establish productive infections in these cells. Using a genetic reassortant approach, we determined that the macrophagotropic property of ARV-176 reflects a post-receptor-binding step in the virus replication cycle and that the ARV-176 M2 genome segment is required for efficient infection of HD-11 cells. The M2 genome segment encodes the major -class outer capsid protein (B) of the virus, which is involved in virus entry and transcriptase activation, suggesting that a host-specific influence on ARV entry and/or uncoating may affect the likelihood of the virus establishing a productive infection in a macrophage cell.The avian reoviruses (ARV) differ from the prototypical mammalian reoviruses (MRV) based on several biological properties other than just their distinct host ranges. Unlike MRV, ARV is naturally pathogenic in its avian host, lacks hemagglutinating ability, and is one of the few nonenveloped viruses capable of inducing syncytium formation in infected cell cultures and in vivo (14,18,24,28). Although ARV pathogenesis has been extensively described (5,6,15,34), the viral factors that influence ARV-host cell interactions and pathogenesis remain poorly understood.We have been investigating two ARV strains that possess distinct pathogenic and syncytium-inducing potentials. Previous results demonstrated that ARV-176 is highly pathogenic relative to ARV-138 in an embryonated egg model of virus pathogenesis, an attribute that correlates with the relative fusogenic capability of the virus (8). Both viruses infect and replicate with equal efficiency in cultured fibroblast cells, they display 94 to 98% amino acid sequence identity in the three sequenced S-class genome segment-encoded proteins (7a), and all 10 of their individual genome segments can be resolved by electrophoretic analysis (8); these properties make these two ARV strains ideal parental virus candidates for genetic and molecular approaches to identify viral determinants of host interaction and pathogenicity. We previously used a genetic reassortant approach to reveal that the S1 genome segment of ARV-176 is solely responsible for the syncytium-inducing property of the virus (8). Subsequent molecular and bio...
Members of our laboratory previously generated and described a set of avian reovirus (ARV) temperaturesensitive (ts) mutants and assigned 11 of them to 7 of the 10 expected recombination groups, named A through G (M. Patrick, R. Duncan, and K. M. Coombs, Virology 284: [113][114][115][116][117][118][119][120][121][122] 2001). This report presents a more detailed analysis of two of these mutants (tsA12 and tsA146), which were previously assigned to recombination group A. The capacities of tsA12 and tsA146 to replicate at a variety of temperatures were determined. Morphological analyses indicated that cells infected with tsA12 at a nonpermissive temperature produced ϳ100-fold fewer particles than cells infected at a permissive temperature and accumulated core particles. Cells infected with tsA146 at a nonpermissive temperature also produced ϳ100-fold fewer particles, a larger proportion of which were intact virions. We crossed tsA12 with ARV strain 176 to generate reassortant clones and used them to map the temperature-sensitive lesion in tsA12 to the S2 gene. S2 encodes the major core protein A. Sequence analysis of the tsA12 S2 gene showed a single alteration, a cytosine-to-uracil transition, at nucleotide position 488. This alteration leads to a predicted amino acid change from proline to leucine at amino acid position 158 in the A protein. An analysis of the core crystal structure of the closely related mammalian reovirus suggested that the Leu 158 substitution in ARV A lies directly under the outer face of the A protein. This may cause a perturbation in A such that outer capsid proteins are incapable of condensing onto nascent cores. Thus, the ARV tsA12 mutant represents a novel assembly-defective orthoreovirus clone that may prove useful for delineating virus assembly.Avian reoviruses (ARVs) are members of the Orthoreovirus genus of the family Reoviridae. ARVs generally are considered to be similar to their mammalian counterparts in structure and molecular composition (40,43). Both ARVs and mammalian reoviruses (MRVs) have a genome consisting of 10 segments of double-stranded RNA (dsRNA) enclosed by a doubleshelled capsid made from eight different proteins. The ARV outer capsid contains three proteins (the major proteins B and B and the minor protein C), and the inner core structure is composed of five proteins (the major core proteins A and A, the core spike protein C, and the minor core proteins B and A) (25, 26). ARVs are important pathogens of poultry that may cause considerable economic losses in poultry farming (reviewed in references 22, 37, and 44). Although their pathological effects have been extensively investigated, the basic biology, structure, function, and assembly of ARVs remain poorly understood.The segmented natures of reovirus genomes, the monocistronic nature of virtually all of the gene segments, and straindependent mobility differences of the genes in polyacrylamide gels have provided intertypic reassortants for use, and these genetic tools have been extensively used to assign biologic f...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.